reason report weekli
histor week readili put behind us solac
fact medic devic index outperform broad market
index declin week versu
 loss result medic devic
hospit suppli modestli outperform
versu year-to-d loss
lie ahead calendar earn season behind us
major industri confer cancel due concern
corpor travel temporarili suspend week ahead look
provid opportun revisit coverag univers in-
depth basi look relat report immedi near term
full year oper result demonstr
compani core busi continu deliv organ growth
excess on-going gross margin expans materi reduc
cash burn rate regulatori file progress eu
plan continu favor esta posit within aesthet
reconstruct marketplac view compani long-term
winner high margin privat pay segment accordingli
encourag investor look next period
accumul esta share posit high growth
favor margin industri leader longer term
also monday publish note rate follow
host compani ndr highlight share
pull back market despit benefit rel
inelast demand compani core franchis vision care
birth control fertil compani limit exposur china
revenu accordingli encourag investor revisit
high-qual recur revenu busi rel valuat
becom attract misight first fda approv
therapi myopia control children age remain
underappreci secular growth driver compani
remain invest year mitig realiz typic rate
oper leverag long-term margin bogey remain
achiev lastli total debt cap compani
coverag ratio remain
addit publish industri piec assess
rel perform broader healthcar sector
import disclosur analyst certif page report report constitut compendium report cover six
subject compani stephen inc choos provid specif disclosur compani mention refer
access current disclosur compani report client refer
contact stephen inc repres addit inform
valuat specif medic devic hospit suppli coverag univers follow prior week
oil shock relat market correct surprisingli healthcar remain one resili sub-sector
rel trade high calendar year-to-d perform yet despit fact note elgx
esta valu compani respect trough valuat
screen favor use modifi dodd framework
e/v rate elgx receiv fda approv compani alto abdomin stent graft system follow regulatori
submiss includ elev investig devic exempt clinic studi furthermor first patient
follow commerci launch includ post approv imag studi order determin consist devic
select elgx intern imag servic implant physician addit elgx note
compani anticip improv short-term outcom rel ovat ix abdomin stent graft system
continu offer ovat period time follow commerci launch alto
tuesday march e/v rate elgx announc appoint jane kiernan compani board director
effect march specif ms kiernan appoint serv audit committe nomin
govern complianc committe ms kiernan previous serv ceo board member salter lab
 follow year baxter healthcar corpor rate held variou execut
gener manag role
wednesday march publish note follow o/v rate esta close rel broad
market declin opinion creat extrem valuat disconnect valu esta
revenu importantli esta deriv commerci sale unit state materi impact
trump administr edict defer elect procedur addit compani excess million
cash million burn rate impli ampl financi liquid persever crisi emerg
industri leader pandem absolv lastli remind investor billion breast
aesthet industri possibl counterintuit stabl financi crisi individu invest enhanc
appear downturn near-term outlook challeng esta rel perform
simpli great even highli volatil uncertain market environ
also wednesday sec releas show o/v rate board director appoint dr gilbert
kliman compani compens committe follow recommend compens nomin
govern committe
thursday march reduc former price target share conjunct
downward revis revenu earn expect compani compani indic
deceler sale growth emea unit state would materi affect oper result
addit reiter pend acquisit exocad global hold gmbh expect close
period use cash hand reduc estim price target note normal
market condit valuat industri lead profit franchis million net cash
compel accordingli durat social econom malais definit assess review
invest rate simpli put possess industri lead high-margin franchis within potenti
million patient persist post pandem
also thursday publish industri report highlight name coverag univers expos revenu
headwind associ non-essenti surgic procedur elect surgic procedur defer
increas pace across countri case acut care set also asc wednesday
announc non-essenti medic surgic dental procedur defer outbreak
associ capac resourc preserv influx critic ill advers effect medic
devic manufactur whose product servic util elect procedur clear research show
elect procedur remain on-going provid respons provis procedur vari geographi
procedur type howev expect near-term result advers affect follow compani alc
also expect demand elect office-bas procedur
diminish near term
summar current state liquid medic devic hospit suppli coverag univers overal
cover compani possess strong balanc sheet nomin short-term liquid requir strong cash
flow characterist meet need importantli elgx recent address prior balanc sheet concern
none cover compani duress risk becom compromis liquid perspect
nearer term assum economi begin march toward return normal oper environ late
simpli put posit weather storm success pass side prevail crisi
notabl outsid coverag monday march american dental associ ada issu
recommend delay elect procedur week order prevent spread ada
also issu detail guidanc wednesday march case consid dental emerg
vs elect
also monday trump administr announc expans telehealth servic medicar beneficiari
specif medicar pay doctor hospit telehealth visit includ wide rang provid
nurs practition clinic psychologist social worker importantli telehealth visit reimburs
amount in-person visit furthermor hh announc relax hippa requir allow doctor
provid telehealth servic person phone diagnost treatment purpos
tuesday march american societi cataract refract surgeri ascr announc cancel
societi annual meet specif meet schedul held may may boston
wednesday march sight scienc inc privat announc close million seri prefer
stock financ use clinic oper develop compani omni tearcar
note dollar million except per share data ep alc
elgx fulli tax pro forma
rate stephen inc overweight equal-weight underweight volatil susp suspend
percentag chang price
insulet corporati
insulet corporati
edward lifesci corporati
compani document stephen inc estim rate
stephen inc otherwis estim base upon consensu
list figur page
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
